There are many other metabolic and endocrine disorders, some of which are very common (lipid, thyroid and mineral disorders) while some others are quite rare.

The development of new therapies in many of these indications has remained slow - some disorders have received attention while others have not seen significant advances in many years. Many important unmet medical needs exist within these areas and there are significant opportunities for organizations and firms with the vision to develop novel therapeutics for these diseases.

• thyroid disorders
• hyperparathyroid disorders and other
  mineral/electrolyte disorders
• metabolic bone diseases other than osteoporosis
• complications of cancer and its treatment
• hypogonadism
• pituitary/growth
• adrenal
• lipids